An overview of drug combination analysis with isobolograms.
about
What is synergy? The Saariselkä agreement revisitedTargeting the biophysical properties of the myeloma initiating cell niches: a pharmaceutical synergism analysis using multi-scale agent-based modelingApplication of multi-target phytotherapeutic concept in malaria drug discovery: a systems biology approach in biomarker identificationPeripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptiveIn-depth analysis shows synergy between erlotinib and miR-34aTargeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistanceTherapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elementsBenchmark dose profiles for joint-action continuous data in quantitative risk assessment.The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.Water contamination reduces the tolerance of coral larvae to thermal stress.On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical dataAn Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.Rational Polytherapy with Antiepileptic Drugs.Oxycodone combinations for pain relief.Synaptic mechanism for functional synergism between delta- and mu-opioid receptors.RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer.Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphomaPerifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesotheliomaEmax model and interaction index for assessing drug interaction in combination studies.Combined treatment of xenon and hypothermia in newborn rats--additive or synergistic effect?Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy.Tapentadol in pain management: a μ-opioid receptor agonist and noradrenaline reuptake inhibitor.Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.Analgesic synergy between opioid and α2 -adrenoceptorsμ-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neuronsStreptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides.Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells.Self-administration of drug mixtures by monkeys: combining drugs with comparable mechanisms of actionCombined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in miceThe fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeysEffects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'.The use of occupation isoboles for analysis of a response mediated by two receptors: M2 and M3 muscarinic receptor subtype-induced mouse stomach contractionsCompensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanismAssessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J MiceRevisiting the isobole and related quantitative methods for assessing drug synergismInteractions between drugs and occupied receptors.Synergistic effects and related bioactive mechanism of Potentilla fruticosa L. leaves combined with Ginkgo biloba extracts studied with microbial test system (MTS).
P2860
Q26782977-9A1B9429-4754-4994-B06F-3A6B17FCF92DQ27334339-2C69DB82-8F88-4E78-9CE5-B849BBADD62BQ28077952-60B226C3-1D9C-4867-B58F-D2C2AF82AC8BQ28396233-6DD1F9CA-931C-4C9F-A5C7-45D4B0A4C42AQ28539851-8F0BB3B7-217E-41EA-9342-95CB8FE91C61Q28546636-E4C98719-EC4F-485F-B980-E665D41B7241Q28610460-AC78412E-E464-4A45-998D-B86ABDD520B1Q30655255-1C04B44B-0718-4F4C-84FA-E6D080C4A736Q30733453-C4EEEEA6-6DC1-4C87-BFB1-05DF79C4D102Q31011100-18320767-BD8B-4971-8F28-FF5CEAC772D5Q33522859-60057407-2BFA-4449-AC25-CFC651043F05Q33580906-8A47EFF3-BFF8-4BDD-A4B3-30B1A331228CQ33664046-A5685240-8F8C-469F-9168-7CD3E2892839Q33713626-69076042-5E3B-418D-92D3-E5B8BCF26834Q33806664-6E59D3EC-E1AB-4D6F-9EA5-ED13940F770FQ34008663-DD1D2F5A-0EA1-4D51-BE14-0E80121D2AEAQ34125281-A827BEF7-E70A-4C2E-B92D-21D793D27AADQ34144940-F13D0643-A1C2-4287-8DD2-54734F454267Q34271064-1E52FF43-BA02-4D03-BAF5-E72E7A95736BQ34282170-055C6A08-FFF1-440A-A35C-0D93BB66025CQ34294500-3D1E2B56-ACDA-4921-9E81-39C9C9B3C7CEQ34585992-4DA4A093-7696-4BCA-83D2-840509E5F465Q34628322-F3E11BB8-80A1-4016-9B77-688E84BB44DFQ34701089-D2EBF340-D0DD-4C14-A077-0841F141654AQ34788066-884635C9-BF22-4B77-9A36-81A6E4871509Q34939644-E2CB2F2D-0D90-4FB3-BCD3-916DE2C680F2Q34939720-85153329-8EF3-402E-9C27-9DC3664F6567Q34971908-079EABBC-AF2F-485F-9509-7BCBC479BBACQ35013544-6FB61B63-0B25-4072-A1D4-FA51AB99E0B5Q35029313-9CFAC2BF-947C-4BB3-8840-DDA034A06E6FQ35223920-4FBDEF09-7065-45D4-A505-C2003CDFECE1Q35287465-0CD058CB-B352-4302-A794-73B1B034B3CAQ35645883-3558C03B-781F-45E0-979E-5366B16692FEQ35751766-4C8A3AD8-614D-4840-93D8-6C08385327C4Q35814984-E2E2C2C8-8CB8-4B63-95FA-11BC70B1FC7BQ35845089-9E1FD0A1-D0B0-438D-BE38-5018159E0FE1Q35889376-BC3F389E-3D2D-47F9-BB0B-124136314EF0Q36057956-4219FDB0-8C36-45A0-8E30-6AC25176084CQ36099198-71D25D50-6646-4C02-8F5E-76C43D3BC6A8Q36209166-963B2F31-56C3-4DC3-9848-8D026EAAFCD0
P2860
An overview of drug combination analysis with isobolograms.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
An overview of drug combination analysis with isobolograms.
@ast
An overview of drug combination analysis with isobolograms.
@en
type
label
An overview of drug combination analysis with isobolograms.
@ast
An overview of drug combination analysis with isobolograms.
@en
prefLabel
An overview of drug combination analysis with isobolograms.
@ast
An overview of drug combination analysis with isobolograms.
@en
P356
P1476
An overview of drug combination analysis with isobolograms.
@en
P356
10.1124/JPET.106.104117
P407
P577
2006-05-02T00:00:00Z